Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$270K Sell
16,972
-46
-0.3% -$713 0.01% 836
2026
Q1
$230K Sell
17,018
-2,246
-12% -$31.4K 0.01% 835
2025
Q4
$240K Buy
19,264
+4,714
+32% +$50.9K 0.01% 813
2025
Q3
$144K Buy
+14,550
New +$142K 0.01% 800
2025
Q2
Sell
-17,217
Closed -$150K 787
2025
Q1
$150K Sell
17,217
-1,015
-6% -$10.7K 0.01% 563
2024
Q4
$227K Buy
18,232
+4,594
+34% +$56.5K 0.02% 481
2024
Q3
$158K Sell
13,638
-1,760
-11% -$20.3K 0.01% 451
2024
Q2
$164K Buy
15,398
+2,139
+16% +$23.6K 0.02% 431
2024
Q1
$158K Buy
13,259
+586
+5% +$7.06K 0.02% 436
2023
Q4
$137K Buy
+12,673
New +$121K 0.01% 439

Other funds holding VTRS

Syon Capital's VTRS Position: Q2 2026 in Review

Syon Capital reduced its Viatris (VTRS) stake by 0.27% in Q2 2026, selling an estimated $713 and leaving 16,972 shares worth $270K. The position accounts for 0.01% of the portfolio, ranked #836.

Syon Capital first reported a position in VTRS in Q4 2023 and has held it in 10 quarters since. 1,026 funds tracked by Wall St. Rank hold VTRS as of Q2 2026.

  • Syon Capital held 16,972 shares of Viatris worth $270K as of Q2 2026.
  • Syon Capital sold 46 Viatris shares in Q2 2026, an estimated $713.
  • Viatris made up 0.01% of Syon Capital's portfolio in Q2 2026, its #836 holding.
  • Syon Capital first reported a position in Viatris in Q4 2023 and has held it in 10 quarters since.
  • 1,026 funds tracked by Wall St. Rank held Viatris as of Q2 2026.

Based on Syon Capital's 13F filing for Q2 2026, filed 14 Aug 2026.